by: Parent Project Muscular Dystrophy
On August 24, 2022, PPMD was joined by Sarepta Therapeutics for a community webinar to present a SRP-9001 gene therapy data update from Studies 101, 102, and 103, following their recent presentation at a medical conference in July.
If you missed the live event, the recording can be found below.*
